|
|
|||
| |||||||||||||||||||||||||||||||||||||||||||||||||
Eosinophilia may be primary or secondary. In patients with secondary eosinophilia, hematopoietic cells are normal and the increased production of eosinophils is a cytokine-driven reactive process. In patients with primary eosinophilia, there is an acquired abnormality of a hematopoietic stem cell. In some cases, differentiation is mainly to cells of the eosinophil
References
Related Letters:
Hypereosinophilic Syndrome
Loughlin K. R., Leone J. L., Bain B. J.
Extract |
Full Text
N Engl J Med 2000;
342:442-443, Feb 10, 2000.
Correspondence
Idiopathic Eosinophilia
Guitart J., Roufosse F., Schandené L., Cogan E., Suzuki R., Seto M., Nakaura S., Simon H.-U., Dummer R.
Extract |
Full Text
N Engl J Med 2000;
342:659-661, Mar 2, 2000.
Correspondence
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |